Felipe Ades
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Cancer Treatment and Pharmacology
Papers in
- Oncology 20
- HER2/EGFR in Cancer Research 10
- Cancer Treatment and Pharmacology 5
- Colorectal Cancer Treatments and Studies 4
- Cancer Immunotherapy and Biomarkers 3
-
- Breast Cancer Treatment Studies 9
- Cancer Genomics and Diagnostics 3
- Co-authors
- Evandro de Azambuja (17 shared papers)Martine Piccart (9 shared papers)Dimitrios Zardavas (10 shared papers)Ivana Božović‐Spasojević (4 shared papers)Christos Sotiriou (2 shared papers)Debora Fumagalli (2 shared papers)Lina Pugliano (3 shared papers)Giuseppe Viale (1 shared paper)
- Journals
- Annals of Oncology (6 papers)The Breast (4 papers)Journal of Clinical Oncology (4 papers)PLoS ONE (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- BelgiumBrazilUnited States
In The Last Decade
Felipe Ades
32 papers receiving 891 citations
Peers
Comparison fields: 5 of 93
- Cancer Research 299
- Oncology 410
- Pulmonary and Respiratory Medicine 166
- Pathology and Forensic Medicine 54
- Family Practice 5
Countries citing papers authored by Felipe Ades
This map shows the geographic impact of Felipe Ades's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felipe Ades with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felipe Ades more than expected).
Fields of papers citing papers by Felipe Ades
This network shows the impact of papers produced by Felipe Ades. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felipe Ades. The network helps show where Felipe Ades may publish in the future.
Co-authors
The 25 scholars most cited alongside Felipe Ades, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 312 | |
| 2 | 2013 | 85 | |
| 3 | 2016 | 84 | |
| 4 | 2023 | 66 | |
| 5 | 2013 | 57 | |
| 6 | 2017 | 41 | |
| 7 | 2014 | 41 | |
| 8 | 2023 | 32 | |
| 9 | 2023 | 29 | |
| 10 | 2020 | 23 | |
| 11 | 2011 | 13 | |
| 12 | 2017 | 13 | |
| 13 | 2014 | 13 | |
| 14 | 2005 | 12 | |
| 15 | 2018 | 11 | |
| 16 | 2023 | 10 | |
| 17 | 2015 | 10 | |
| 18 | 2011 | 9 | |
| 19 | 2017 | 8 | |
| 20 | 2022 | 8 |
About Felipe Ades
Felipe Ades is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Surgery, having authored 35 papers that have together received 915 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (10 papers), Breast Cancer Treatment Studies (9 papers), Cancer Treatment and Pharmacology (5 papers), Lung Cancer Treatments and Mutations (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer Genomics and Diagnostics (3 papers), Advanced Breast Cancer Therapies (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Cancer Research (299 citations), Oncology (410 citations), Pulmonary and Respiratory Medicine (166 citations), Pathology and Forensic Medicine (54 citations) and Family Practice (5 citations). Felipe Ades has collaborated with scholars based in Belgium, Brazil and United States. Frequent co-authors include Evandro de Azambuja, Martine Piccart, Dimitrios Zardavas, Ivana Božović‐Spasojević, Christos Sotiriou, Debora Fumagalli, Lina Pugliano, Giuseppe Viale, Ana Catarina Pinto and Konstantinos Tryfonidis. Their work appears in journals such as Annals of Oncology, The Breast, Journal of Clinical Oncology, PLoS ONE and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.